CVS Health (NYSE:CVS) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.09, beating the consensus estimate of $0.99 by $0.10 per share. Revenue came in at $105.7B, beating the estimate of $103.5B.
CVS Health's stock moved following the earnings release. The stock currently trades at $77.02 with a market capitalization of $102.6B.


